Ulinastatin
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Name
- Ulinastatin
- Accession Number
- DB12038
- Description
Ulinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
- Type
- Biotech
- Groups
- Investigational
- Biologic Classification
- Protein Based Therapies
Other protein based therapies - Protein Chemical Formula
- Not Available
- Protein Average Weight
- Not Available
- Sequences
- Not Available
- Synonyms
- Not Available
Pharmacology
- Indication
- Not Available
- Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More- Pharmacodynamics
- Not Available
- Mechanism of action
- Not Available
- Absorption
- Not Available
- Volume of distribution
- Not Available
- Protein binding
- Not Available
- Metabolism
- Not Available
- Route of elimination
- Not Available
- Half-life
- Not Available
- Clearance
- Not Available
- Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More- Toxicity
- Not Available
- Affected organisms
- Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- ATC Codes
- B02AB05 — Ulinastatin
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- Not Available
- Kingdom
- Organic Compounds
- Super Class
- Organic Acids
- Class
- Carboxylic Acids and Derivatives
- Sub Class
- Amino Acids, Peptides, and Analogues
- Direct Parent
- Peptides
- Alternative Parents
- Not Available
- Substituents
- Not Available
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
Chemical Identifiers
- UNII
- OR3S9IF86U
- CAS number
- 80449-31-6
References
- General References
- Not Available
- External Links
- PubChem Substance
- 347911274
- Wikipedia
- Ulinastatin
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Not Available Abnormal Aortic Valve 1 4 Completed Prevention Cardiovascular Disease (CVD) 1 4 Completed Treatment Cardiopulmonary Bypass / Surgery, Cardiac 1 4 Completed Treatment Coronary Artery Occlusive Disease 1 4 Recruiting Treatment Sepsis / Shock, Septic 1 4 Suspended Treatment Pancreatitis 1 4 Unknown Status Treatment Congenital Heart Disease (CHD) 1 3 Recruiting Treatment Oral Mucositis (Ulcerative) Due to Radiation 1 2 Unknown Status Treatment Acute Respiratory Distress Syndrome (ARDS) 1 2 Unknown Status Treatment Inhalation Injury 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created on October 20, 2016 15:14 / Updated on June 12, 2020 10:53